These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7437530)

  • 1. Evaluation of hypercoagulability after remission induction chemotherapy of acute leukemia.
    Hiller E; Riess H; Hafter R; Graeff H
    Blut; 1980 Nov; 41(5):359-66. PubMed ID: 7437530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment.
    Chojnowski K; Wawrzyniak E; Treliński J; Niewiarowska J; Cierniewski C
    Leuk Lymphoma; 1999 Dec; 36(1-2):77-84. PubMed ID: 10613452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.
    Sterrenberg L; Haak HL; Brommer EJ; Nieuwenhuizen W
    Haemostasis; 1985; 15(2):126-33. PubMed ID: 3859461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of soluble fibrin monomer complexes for evaluation of hypercoagulability during pregnancy and delivery (author's transl)].
    Hafter R; Schneebauer T; Tafel K; Ernst E; Graeff H
    Geburtshilfe Frauenheilkd; 1975 Jul; 35(7):518-25. PubMed ID: 1213264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the role of leukocytes in the activation of intravascular coagulation in septicemia].
    Okajima K; Uchiba M; Okabe H; Takatsuki K
    Rinsho Byori; 1990 Jul; 38(7):799-805. PubMed ID: 2205743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia.
    Asakura H; Saito M; Ito K; Jokaji Y; Uotani C; Kumabashiri I; Matsuda T
    Thromb Res; 1988 Jun; 50(6):895-9. PubMed ID: 3166241
    [No Abstract]   [Full Text] [Related]  

  • 11. Normal levels of antithrombin III in acute leukemia complicated by coagulopathy.
    Vellenga E; Mulder NH
    Acta Haematol; 1980; 63(6):336-8. PubMed ID: 6774570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation studies in patients with acute leukemia before and after cytostatic chemotherapy].
    Bhaduri S; Rasche H; Köhle W; Dietrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1142-4. PubMed ID: 611807
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery?
    Feindt P; Seyfert U; Volkmer I; Huwer H; Kalweit G; Gams E
    Eur J Cardiothorac Surg; 1994; 8(6):308-13; discussion 313-4. PubMed ID: 7522017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid estimation of soluble fibrin monomer complexes by high performance liquid chromatography for the purpose of early detection of DIC.
    Ishikawa A; Iwasaki Y
    Thromb Res; 1983 Jun; 30(5):521-6. PubMed ID: 6612682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercoagulability and DIC in high-risk infants.
    Suzuki S; Morishita S
    Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
    Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
    Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypercoagulability in septic abortion.
    Graeff H; Ernst E; Bocaz JA; von Hugo R; Hafter R
    Haemostasis; 1976; 5(5):285-94. PubMed ID: 1017723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.